New York’s supply of COVID-19 antiviral pills has increased significantly since February as BA.2 omicron subvariant spreads across state.
The state supply of antiviral pills has increased threefold, with the current statewide supply of Pfizer and Merck antiviral pills at 114,000 compared to the 34,000 available on February 2, 2022, according to The Evening Tribune.
Additionally, the state had about 18,000 Astra Zeneca and Eli Lilly monoclonal antibody treatment courses, which were distributed regionally based on population. The Department of Health requested medical providers consider a number of factors in prioritizing high-risk patients, including age, vaccination status, and existing health conditions.
Health officials said those who test positive for COVID should contact their health providers for more information about accessing prescription treatments. You can also call the federal vaccine hotline at 1-800-232-0233 for more information.